KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Elevance Health (ELV) Cash from Investing Activities (2016 - 2025)

Elevance Health (ELV) has disclosed Cash from Investing Activities for 17 consecutive years, with $464.0 million as the latest value for Q4 2025.

  • On a quarterly basis, Cash from Investing Activities rose 128.33% to $464.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$1.3 billion, a 73.99% increase, with the full-year FY2025 number at -$1.3 billion, up 73.99% from a year prior.
  • Cash from Investing Activities was $464.0 million for Q4 2025 at Elevance Health, up from -$1.2 billion in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $464.0 million in Q4 2025 to a low of -$4.9 billion in Q2 2021.
  • A 5-year average of -$1.3 billion and a median of -$1.1 billion in 2023 define the central range for Cash from Investing Activities.
  • Peak YoY movement for Cash from Investing Activities: crashed 1717.98% in 2021, then soared 129.92% in 2022.
  • Elevance Health's Cash from Investing Activities stood at -$966.0 million in 2021, then surged by 129.92% to $289.0 million in 2022, then crashed by 456.06% to -$1.0 billion in 2023, then plummeted by 59.18% to -$1.6 billion in 2024, then surged by 128.33% to $464.0 million in 2025.
  • Per Business Quant, the three most recent readings for ELV's Cash from Investing Activities are $464.0 million (Q4 2025), -$1.2 billion (Q3 2025), and -$687.0 million (Q2 2025).